.blurhash-client-img { display: none !important; }

Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci

Postępy Higieny i Medycyny Doświadczalnej

Volume 76 (2022): Issue 1 (January 2022)

By: Tomasz Jarzembowski , Agnieszka Daca , Wiesław J. Cubała , Marek Bronk and Łukasz Naumiuk

Open Access

|Aug 2022

Authors

Tomasz Jarzembowski

tjarzembowski@gumed.edu.pl

Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland

Agnieszka Daca

Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland

Wiesław J. Cubała

Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland

Marek Bronk

Department of Clinical Microbiology, Hospital of the Medical University of Gdansk, Poland

Łukasz Naumiuk

Department of Clinical Microbiology, Hospital of the Medical University of Gdansk, Poland

DOI: https://doi.org/10.2478/ahem-2022-0047 | Journal eISSN: 1732-2693

Journal RSS Feed

Language: English

Page range: 333 - 338

Submitted on: Jan 3, 2022

Accepted on: May 11, 2022

Published on: Aug 9, 2022

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

phagocytosis resistance,

Related subjects:

Molecular biology,

Microbiology and virology,

Basic medical science,

© 2022 Tomasz Jarzembowski, Agnieszka Daca, Wiesław J. Cubała, Marek Bronk, Łukasz Naumiuk, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 76 (2022): Issue 1 (January 2022)Next article